CrushSCI.com
77.2Average days
66Median days
13Fastest days
176Longest days
7352025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

40 days

When the Right Ventricle Becomes the Teacher: Lessons From Acute Right Heart Failure

Authors
ALEXANDRA MIHAIShow moreShow less
Affiliations
Department of Clinical and Cardiovascular Sciences, Sapienza University of Rome, Rome, ItalyShow moreShow less
Source PDF DOI Publisher page
124 days

Generating Much-Needed Heart Failure-Related Outcome Data in Sub-Saharan Africa: Insights From the Ibadan Heart Failure Project

Authors
OKECHUKWU S. OGAH; OLANIKE A. ORIMOLADE; CHUKWUEMEKA L. ANYIKWA; AGOZIE ONUIGBO; ABDULHAMMED BABATUNDE; OBAKAYODE J. ADEMOLA; CHIDINMA M. OGAH; ADEWOLE ADEBIYI; SIMON STEWARTShow moreShow less
Affiliations
Cardiology Unit, Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria; Cardiology Unit, Department of Medicine, University College Hospital, Ibadan, Oyo State, Nigeria; Cardiomyopathies, Heart Failure and Atrial Fibrillation Research Projects, Cardiology Unit, Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria; Institute for Health Research, The University of Notre Dame, Fremantle, Western Australia, Australia; Faculty of Medicine, Universidade Eduardo Mondlane, Maputo, Mozambique; Department of Medicine, Cape Heart Institute, University of Cape Town, Rondebosch, Cape Town, South AfricaShow moreShow less
Source PDF DOI Publisher page
44 days

Clinical Characteristics, Treatment Patterns, and Outcomes of Patients with Worsening Heart Failure Managed with Outpatient Intravenous Diuretics

Authors
BEST UCHEHARA; G. MICHAEL FELKER; TODD MCVEIGH; MARGARET T. BOWERS; MEGHA GUPTA; BRADLEY G. HAMMILL; JAVED BUTLER; GREGG C. FONAROW; ADRIAN F. HERNANDEZ; STEPHEN J. GREENEShow moreShow less
Affiliations
Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina; Baylor Scott and White Research Institute, Dallas, Texas; Department of Medicine, University of Mississippi, Jackson, Mississippi; Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles, Los Angeles, CaliforniaShow moreShow less
Source PDF DOI Publisher page
71 days

Residual Risk of Hyperkalemia Among Patients with Heart Failure Treated with Both SGLT2i and ARNI

Authors
STEPHEN J. GREENE; SHACHI PATEL; KHAJA CHINNAKONDEPALLI; STEFAN D. ANKER; MICHAEL BÖHM; BIYKEM BOZKURT; JAVED BUTLER; JOHN GF. CLELAND; ANDREW J. COATS; NIHAR DESAI; VICTORIA DONACHIE; ELLIE KELEPOURIS; GIUSEPPE ROSANO; CARLA-MARIA BRANDES; ANDREW J. SAUERShow moreShow less
Affiliations
Duke Clinical Research Institute, Durham, North Carolina; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Saint Luke’s Mid America Heart Institute and University of Missouri, Kansas City, Missouri; Department of Cardiology (CVK) of German Heart Center Charité and German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany; HOMICAREM (HOMburg Institute for CArdioREnalMetabolic Medicine), Saarland University, Homburg (Saar), Germany; Winters Center for Heart Failure Research, Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas; Baylor Scott and White Research Institute, Dallas, Texas; University of Mississippi Medical Center, Jackson, Mississippi; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom; Heart Research Institute, Sydney, Australia; Section of Cardiovascular Medicine, Yale School of Medicine, Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut; CSL Vifor, Glattbrugg, Switzerland; Division of Renal Electrolyte and Hypertension, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Human Sciences and Promotion of Quality of Life, San Raffaele Open University of Rome, Rome, Italy; IRCCS San Raffaele, Rome, ItalyShow moreShow less
Source PDF DOI Publisher page
124 days

The Effect of Empagliflozin on Left Ventricular Mass and Volumes in Older Adult Individuals With Overweight and High Risk of Heart Failure: The Empire Prevent Cardiac Trial

Authors
JULIE HEMPEL LARSEN; CAMILLA FUCHS ANDERSEN; MARIA CALLESEN HANSEN; MASSAR OMAR; JESPER JENSEN; LISBETH ANTONSEN; PER LAV MADSEN; JULIE LYNG FORMAN; KURT HØJLUND; FILIP KRAG KNOP; MIKAEL KJÆR POULSEN; MORTEN SCHOU; JACOB EIFER MØLLERShow moreShow less
Affiliations
Department of Cardiology, Odense University Hospital, Odense, Denmark; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte University Hospital, Herlev, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; The August Krogh Section for Human Physiology NEXS, Copenhagen University, Copenhagen, Denmark; Section of Biostatistics, Department of Public Health, University of Copenhagen University, Copenhagen, Denmark; Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark; Department of Clinical Metabolic Research, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark; Department of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, DenmarkShow moreShow less
Source PDF DOI Publisher page
13 days

Increased Federal Oversight of Donation After Circulatory Death Heart Transplant: Time for a Pause?

Authors
H. LUISE HOLZHAUSER; JENNA SKOWRONSKI; MARYJANE FARRShow moreShow less
Affiliations
University of Pennsylvania, Philadelphia, PA; University of North Carolina, Chapel Hill, Chapel Hill, NCShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF CARDIAC FAILURE take to review a manuscript?

As of 2026-11-19, CrushSCI has 15 complete review records for JOURNAL OF CARDIAC FAILURE. The fastest paper went from submission to acceptance in 13 days (Increased Federal Oversight of Donation After Circulatory Death Heart Transplant: Time for a Pause?, received 2026-02-06, accepted 2026-02-19); the slowest took 176 days. The average is 77.2 days and the median is 66 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.